Clinical trial

Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction

NCT05556044

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-09-27

PhasePHASE3

Study timeline

Study start (actual)2022-09-27Date precision: day

Registry last updated2024-02-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acute Heart Failureunresolved

Interventions

Empagliflozin 10 MGDRUG · verified · RxNorm: empagliflozin 10 MG

Sponsors & collaborators

Chinese University of Hong Konglead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05556044 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.